CAS 186691-13-4

(1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide BA 679 BR BA 679BR BA-679 BR BA-679-BR D0P1WA Spiriva Spiriva (TN) Spiriva Handihaler Spiriva Respimat TIOTROPIUM BROMIDE Tiotropium Tiotropium bromide [USAN:INN]

纯度 97%+现货药物标准品
CAS 号186691-13-4
分子式C19H22NO4S2
分子量392.51 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 (1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide
(1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
186691-13-4
7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide
7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
BA 679 BR
BA 679BR
BA-679 BR
BA-679-BR
D0P1WA
Spiriva
Spiriva (TN)
Spiriva Handihaler
Spiriva Respimat
TIOTROPIUM BROMIDE
Tiotropium
Tiotropium bromide [USAN:INN] CAS 186691-13-4 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品((1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide BA 679 BR BA 679BR BA-679 BR BA-679-BR D0P1WA Spiriva Spiriva (TN) Spiriva Handihaler Spiriva Respimat TIOTROPIUM BROMIDE Tiotropium Tiotropium bromide [USAN:INN],CAS 186691-13-4),分子式 C19H22NO4S2,分子量 392.51。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

在现行药典和法规框架下,药物标准品的合规要求中明确涉及对包括在内的目标物的控制。 CAS编号 186691-13-4 对应的化合物(英文标识 (1A,2A,4A,5A,7A)-7-(Hydroxydi-2-thienylacetyl)oxy-9,9-dimethyl-3-oxa-9-azoniatri-cyclo3.3.1.02.4nonane bromide (1a,2,4,5a,7)-7-(2-Hydroxy-2,2-di-2-thienylacetyl)oxy-9,9-dimethyl-3-oxa-9-azoniatricyclo3.3.1.02,4nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide 7-{hydroxy(dithiophen-2-yl)acetyloxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo3.3.1.

应用场景:((1A,2A,4A,5A,7A)-7- (Hydroxydi-2-thienylacetyl)oxy -9,9-dimethyl-3-oxa-9-azoniatri-cyclo 3.3.1.02.4 nonane bromide (1a,2,4,5a,7)-7- (2-Hydroxy-2,2-di-2-thienylacetyl)oxy -9,9-dimethyl-3-oxa-9-azoniatricyclo 3.3.1.02,4 nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-ox

理化性质 Physical & Chemical Properties

中文名称
分子式C19H22NO4S2
分子量392.51 g/mol
外观形态淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)
纯度97%+
储存条件2-8°C冷藏保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)9.5
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2010年
含氮原子数1
含硫原子数2

相关专利 Related Patents

  1. 发明人杨光,冯建国,朱建伟. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 111422166 A, 授权公告日 2022-10-05.
  2. 发明人杨光,高志强,胡光. "Method for the Synthesis of (1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide BA 679 BR BA 679BR BA-679 BR BA-679-BR D0P1WA Spiriva Spiriva (TN) Spiriva Handihaler Spiriva Respimat TIOTROPIUM BROMIDE Tiotropium Tiotropium bromide [USAN:INN]" [P]. 中国发明专利, 专利号 CN 111274919 B, 授权公告日 2017-03-21.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2021, 511, (6), 3006-3033.
  2. Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2013, 2274, (6), 9239-9255.
  3. O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of (1A,2A,4A,5A,7A)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatri-cyclo[3.3.1.02.4]nonane bromide (1a,2,4,5a,7)-7-[(2-Hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide 186691-13-4 7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide 7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide BA 679 BR BA 679BR BA-679 BR BA-679-BR D0P1WA Spiriva Spiriva (TN) Spiriva Handihaler Spiriva Respimat TIOTROPIUM BROMIDE Tiotropium Tiotropium bromide [USAN:INN] Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2011, 2280, 6855-6875.
  4. O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2024, 1821, (7), 6687-6700.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...